August 8, 2024 – Abbott introduced a novel world collaboration with Medtronic to collaborate on an built-in steady glucose monitoring (CGM) system primarily based on Abbott’s most superior, industry-leading FreeStyle Libre know-how that connects to Medtronic’s automated insulin supply (AID) and good insulin pen methods.

The mixing of Abbott's CGM sensor with Medtronic's AID algorithms will allow automated insulin changes to maintain glucose in vary. The CGM sensor, designed to work solely with Medtronic gadgets, might be developed by Abbott and offered by Medtronic.

AID methods enhance well being outcomes and cut back the burden of fixed decision-making for folks with diabetes who use intensive insulin as a part of their general remedy. AID methods can profit folks with each sort 1 and kind 2 diabetes who require a number of every day injections of rapid-acting insulin, presently estimated at greater than 11 million folks worldwide.

Extra info